Skip to main content

Carbinoxamine / methscopolamine / pseudoephedrine Pregnancy and Breastfeeding Warnings

Brand names: Nacon, Pannaz, Pannaz S, Pseudox M

Carbinoxamine / methscopolamine / pseudoephedrine Pregnancy Warnings

Carbinoxamine/methscopolamine/pseudoephedrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. Carbinoxamine/methscopolamine/pseudoephedrine is only recommended for use during pregnancy when benefit outweighs risks.

See references

Carbinoxamine / methscopolamine / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of carbinoxamine/methscopolamine/pseudoephedrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. Product Information. Pannaz (carbinoxamine/methscopolamine/pseudoephedrine). Alfasigma USA Inc (formerly Pamlab LLC). 2004.

References for breastfeeding information

  1. Product Information. Pannaz (carbinoxamine/methscopolamine/pseudoephedrine). Alfasigma USA Inc (formerly Pamlab LLC). 2004.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.